Use of botulinum toxin type A to control facial pain in a patient with temporomandibular disorder: case report
DOI:
https://doi.org/10.33448/rsd-v9i12.10949Keywords:
Botulinum Toxins, Type A; Temporomandibular Joint Dysfunction Syndrome; Facial Pain.Abstract
Objective: The objective of this article is to report a clinical case in which botulinum toxin type A was applied to the masseter and temporal muscles in order to control pain in a patient diagnosed with Temporomandibular Dysfunction who did not respond to previous treatments, especially for reduction painful symptoms. Methodology: This article is a case report of a clinical, descriptive and analytical nature, which aims to report in detail and based on science, the treatment of a patient who suffered with severe facial pain caused by temporomandibular disorder (TMD). Results: After a careful diagnosis and taking into account the patient's clinical history of previous unsuccessful treatments for remission of painful symptoms, the reduction of pain reported by the patient was achieved through the application of botulinum toxin to the masseter and temporal muscles, as well as a reduction in pain. volume of the muscles that were hypertrophied and increased amplitude of mouth opening. Conclusion: The application of botulinum toxin to a patient suffering from muscle TMD has proven to be an effective therapy in reducing and controlling the pain reported by the patient. However, more studies are needed, with a longer follow-up and more treated patients.
References
Aoki, K. R., & Francis, J. (2011). Updates on the antinociceptive mechanism hypothesis of botulinum toxin A. Parkinsonism & related disorders, 17 Suppl 1, S28–S33. https://doi.org/10.1016/j.parkreldis.2011.06.013
Carrara, S. V., Conti, P. C. R., & Barbosa, J. S. (2010). Statement of the 1st consensus on temporomandibular disorders and orofacial pain. Dental Press Journal of Orthodontics, 15(3), 114-120.
Clark, G. T. (2003). The management of oromandibular motor disorders and facial spasms with injections of botulinum toxin. Physical Medicine and Rehabilitation Clinics, 14(4), 727-748.
Colhado, O. C. G., Boeing, M., & Ortega, L. B. (2019). Toxina botulínica no tratamento da dor. Brazilian Journal of Anesthesiology, 59(3), 366-381.
Dall'Antonia, M., Netto, R. M. D. O., Sanches, M. L., & Guimarães, A. S. (2013). Dor miofascial dos músculos da mastigação e toxina botulínica. Revista Dor, 14(1), 52-57.
Dressler, D., & Saberi, F. A. (2005). Botulinum toxin: mechanisms of action. European neurology, 53(1), 3-9.
Ernberg, M., Hedenberg-Magnusson, B., List, T., & Svensson, P. (2011). Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study. Pain, 152(9), 1988-1996.
Ferri, C. de F., Pissaia, P., Cavalheiro, S., Barbosa, B., Zen, A. S., Imanishi, S., Da Silva Muniz, M., & Dirschanabel, A. J. (2016). Toxina Botulínica Na Odontologia. Ação Odonto, (1).
Francisco, S. F. G., & do Nascimento, T. B. (2019). A Utilização Da Toxina Botulínica Tipo–A No Tratamento Das Disfunções Temporomandibulares Musculares: Revisão De Literatura Literature Review. Brazilian Journal of Health Review, 2(6), 5654-5666.
Graboski, C. L., Gray, D. S., & Burnham, R. S. (2005). Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: a randomised double blind crossover study. Pain, 118(1-2), 170-175.
Guarda-Nardini, L., Stecco, A., Stecco, C., Masiero, S., & Manfredini, D. (2012). Myofascial pain of the jaw muscles: comparison of short-term effectiveness of botulinum toxin injections and fascial manipulation technique. CRANIO®, 30(2), 95-102.
Leeuw, R. (2010). Disfunção temporomandibular. Leeuw R. Dor orofacial: guia de avaliação, diagnóstico e tratamento, 4.
Naked, S. (2017). Toxina botulínica tipo a na disfunção temporomandibular. Revista Fluminense de Odontologia, 1(47).
Pereira, A. S.; Shitsuka, D. M.; Parreira, F. J. & Shitsuka, R. (2018). Metodologia da pesquisa científica (1 ed.) Santa Maria, RS: UFSM, NTE.
Reis, A. L. M., Braga, G. P., Segantini, L. H. C., Braga, R. P., de Castro Oliveira, U., de Lima, R. F., ... & da Silva, D. B. (2020, October). A Toxina Botulínica no tratamento de DTM muscular. In Congresso Interdisciplinar-ISSN: 2595-7732 (Vol. 5, No. 1, pp. 1-5).
Silva, E. M. R. Toxina botulínica no tratamento das disfunções temporomandibulares e dor orofacial - revisão integrativa. 2017. - Curso de Odontologia, Universidade Estadual da Paraíba, Campina Grande, 2017. Cap. 1
Sposito, M. M. D. M., & Teixeira, S. A. F. (2014). Toxina Botulínica Tipo A no tratamento da dor miofascial relacionada aos músculos da mastigação. Acta fisiátrica.
Teixeira, N. B. A. (2014). Toxina Botulínica, considerações em Medicina Dentária (Doctoral dissertation, [sn]).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Cecília Santos Galvão; Maria Regina Santos Nóbrega; Érika Oliveira de Almeida
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
